These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19318677)

  • 1. Apoptosis-related (survivin, Bcl-2), tumor suppressor gene (p53), proliferation (Ki-67), and non-receptor tyrosine kinase (Src) markers expression and correlation with clinicopathologic variables in 60 thymic neoplasms.
    Khoury T; Arshad A; Bogner P; Ramnath N; Zhang S; Chandrasekhar R; Wilding G; Alrawi S; Tan D
    Chest; 2009 Jul; 136(1):220-228. PubMed ID: 19318677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferative activity and apoptosis in thymic epithelial neoplasms.
    Hiroshima K; Iyoda A; Toyozaki T; Supriatna Y; Shibuya K; Shimamura F; Haga Y; Yoshida S; Fujisawa T; Ohwada H
    Mod Pathol; 2002 Dec; 15(12):1326-32. PubMed ID: 12481014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of apoptosis-related markers and HER-2/neu in thymic epithelial tumours.
    Pan CC; Chen PC; Wang LS; Lee JY; Chiang H
    Histopathology; 2003 Aug; 43(2):165-72. PubMed ID: 12877732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Surgery for thymomas and thymic carcinomas; treatment results in terms of WHO histologic typing, Masaoka staging system, and p53 expression].
    Yamazaki K; Kitada M; Sasaki K; Koshiko S; Hirasawa M; Ozawa K; Kajiura Y; Sasajima T; Miyokawa N
    Kyobu Geka; 2002 Oct; 55(11):949-52. PubMed ID: 12391691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of Epstein-Barr virus, cell proliferation and apoptosis in thymic tumors].
    Mai S; Xiong M; Zong Y; Li Z; Rao H
    Zhonghua Bing Li Xue Za Zhi; 1999 Apr; 28(2):89-92. PubMed ID: 11869513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p53, mdm2, p21/waf1 and bcl-2 proteins in thymomas.
    Stefanaki K; Rontogianni D; Kouvidou CH; Bolioti S; Delides G; Pantelidaki A; Sotsiou F; Kanavaros P
    Histopathology; 1997 Jun; 30(6):549-55. PubMed ID: 9205859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Upregulation of survivin in non-small cell lung cancer and its clinicopathological correlation with p53 and Bcl-2].
    Han PH; Li XJ; Qin H; Yao J; DU N; Ren H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):710-3. PubMed ID: 19664395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53, cellular proliferation, and apoptosis-related factors in thymic neuroendocrine tumors.
    Gal AA; Sheppard MN; Nolen JD; Cohen C
    Mod Pathol; 2004 Jan; 17(1):33-9. PubMed ID: 14631373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological and prognostic significance of p53, Ki-67, and Bcl-2 expression in Tunisian gastric adenocarcinomas.
    Ayed DB; Khabir A; Abid M; Bayrouti MI; Gargouri A; Sellami-Boudawara T; Mokdad-Gargouri R
    Acta Histochem; 2014 Oct; 116(8):1244-50. PubMed ID: 25095748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Ki-67, Bcl-2, Survivin and p53 Proteins in Patients with Pulmonary Carcinoma.
    Halasova E; Adamkov M; Matakova T; Vybohova D; Antosova M; Janickova M; Singliar A; Dobrota D; Jakusova V
    Adv Exp Med Biol; 2013; 756():15-21. PubMed ID: 22836614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid receptor expression in thymomas and thymic carcinomas.
    Mimae T; Tsuta K; Takahashi F; Yoshida A; Kondo T; Murakami Y; Okada M; Takeuchi M; Asamura H; Tsuda H
    Cancer; 2011 Oct; 117(19):4396-405. PubMed ID: 21437890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KI-67 antigen expression predicts survival and correlates with histologic subtype in the WHO classification of thymic epithelial tumors.
    Comin CE; Messerini L; Novelli L; Boddi V; Dini S
    Int J Surg Pathol; 2004 Oct; 12(4):395-400. PubMed ID: 15494865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathologic analysis of 52 cases of thymic epithelial tumor].
    Ma YQ; Miao N; Abulajiang G; Li QX; Liu X; Zhang W; Wang CF; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):249-54. PubMed ID: 20654124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation of expression of P-glycoprotein and inhibitor of apoptosis proteins to chemosensitivity in gastrointestinal carcinoma tissues].
    Han J; Tan BB; Geng W; Lu BR; Zhao JH
    Ai Zheng; 2008 Nov; 27(11):1166-71. PubMed ID: 19000447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study of apoptosis markers and involvement of chemokine CXCR4 in skin Merkel cell carcinoma.
    Tucci MG; Lucarini G; Giangiacomi M; Zizzi A; Criante P; Ricotti G; Biagini G
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1220-5. PubMed ID: 17062035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of aggressiveness of gastrointestinal stromal tumours based on immunostaining with bcl-2, Ki-67 and p53.
    Meara RS; Cangiarella J; Simsir A; Horton D; Eltoum I; Chhieng DC
    Cytopathology; 2007 Oct; 18(5):283-9. PubMed ID: 17883690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysis.
    Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Chikhlikar PR; Ghosh N; Trivedi TI
    Ann Surg Oncol; 2000 May; 7(4):305-11. PubMed ID: 10819372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy.
    Karam JA; Lotan Y; Karakiewicz PI; Ashfaq R; Sagalowsky AI; Roehrborn CG; Shariat SF
    Lancet Oncol; 2007 Feb; 8(2):128-36. PubMed ID: 17267327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.